Latest News

Spring 2016 Issue of Compass Now Available

May 26, 2016
Posted in , ,

The Spring 2016 issue of Compass is now available online. As part of our most recent round of funding, we’ve announced eight grants totaling $890,000 for basic research, and two […]

Read More ›

Cure SMA Awards $300,000 Drug Discovery Grant to Charlotte Sumner, in Collaboration with Imago Pharmaceuticals

May 25, 2016
Posted in ,

Cure SMA has awarded a $300,000 drug discovery grant to Charlotte Sumner, MD, at Johns Hopkins University, in collaboration with Imago Pharmaceuticals. The award is for the project, “Preclinical Development […]

Read More ›

Announcing an Evening of Fun at Disneyland Park

May 24, 2016
Posted in ,

Just added to this year’s conference schedule: Saturday Night at Disneyland Park! We’re very excited to announce that conference attendees will get to take part in this special evening of […]

Read More ›

Cure SMA Releases Full Schedule for the 2016 Annual SMA Conference

May 19, 2016
Posted in , , ,

Cure SMA has released the full schedule for the 2016 Annual SMA Conference, which will be held in Anaheim, CA at Disneyland, June 16-19. The schedule includes the detailed timeline […]

Read More ›

Cure SMA Awards $70,000 Grant to Christine DiDonato, Lurie Children’s Hospital of Chicago

May 17, 2016
Posted in , ,

Cure SMA has awarded a $70,000 research grant to Dr. Christine DiDonato at Lurie Children’s Hospital of Chicago for her project, “Assessing mediators of muscle weakness in SMA mice.” Individuals […]

Read More ›

AveXis Reports Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1

May 6, 2016
Posted in , ,

Today, AveXis, Inc. presented an interim analysis of data as of April 1, 2016 from the ongoing Phase 1 trial of AVXS-101 for the treatment of spinal muscular atrophy (SMA) […]

Read More ›
Scroll to Top